Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity

被引:46
作者
Heinzel, FP
Rerko, RM
Hujer, AM
机构
[1] Case Western Reserve Univ, Sch Med, Div Geog Med, Cleveland, OH 44106 USA
[2] Vet Affairs Med Ctr, Med Res Serv, Cleveland, OH 44106 USA
关键词
D O I
10.1006/cimm.1998.1267
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-12 promotes Th1 lymphocyte responses necessary for the cure of murine Leishmania major infection. We found that IL-12 p40 mRNA expression peaked at 4 weeks of infection in resistant C57BL/6 mice at levels threefold greater than in BALB/c mice. Peak IL-12 p40 expression in both strains was reduced threefold following treatment with neutralizing anti-CD40 ligand antibody and disease worsened in C57BL/6 mice. Direct activation of cultured lymph node cells by anti-CD40 MAb or soluble CD40 ligand failed to restore deficient IL-12 production by infected BALB/c mice unless recombinant IFN-gamma was added to culture. Infected BALB/c lymph nodes also contained two-to threefold fewer low-density CD40(+) accessory cells compared to that in C57BL/6 mice, We conclude that CD40-dependent responses are continually required for healing of leishmaniasis and that progressive disease is associated with decreased CD40-stimulated IL-12 synthesis as a consequence of either altered cytokine environment or inadequate accessory cell number. (C) 1998 Academic Press.
引用
收藏
页码:129 / 142
页数:14
相关论文
共 48 条
[21]   POLYCLONAL B-CELL STIMULATION BY L3T4+ T-CELLS IN EXPERIMENTAL LEISHMANIASIS [J].
LOHOFF, M ;
MATZNER, C ;
ROLLINGHOFF, M .
INFECTION AND IMMUNITY, 1988, 56 (08) :2120-2124
[22]   IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses [J].
Magram, J ;
Connaughton, SE ;
Warrier, RR ;
Carvajal, DM ;
Wu, CY ;
Ferrante, J ;
Stewart, C ;
Sarmiento, U ;
Faherty, DA ;
Gately, MK .
IMMUNITY, 1996, 4 (05) :471-481
[23]   THE DISTINCT LEUKOCYTE INTEGRINS OF MOUSE SPLEEN DENDRITIC CELLS AS IDENTIFIED WITH NEW HAMSTER MONOCLONAL-ANTIBODIES [J].
METLAY, JP ;
WITMERPACK, MD ;
AGGER, R ;
CROWLEY, MT ;
LAWLESS, D ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1753-1771
[24]  
MORRIS L, 1992, J IMMUNOL, V149, P2715
[25]   CD40 and its ligand in host defense [J].
Noelle, RJ .
IMMUNITY, 1996, 4 (05) :415-419
[26]   LEISHMANIA PROMASTIGOTES EVADE INTERLEUKIN 12 (IL-12) INDUCTION BY MACROPHAGES AND STIMULATE A BROAD RANGE OF CYTOKINES FROM CD4(+) T-CELLS DURING INITIATION OF INFECTION [J].
REINER, SL ;
ZHENG, SC ;
WANG, ZE ;
STOWRING, L ;
LOCKSLEY, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :447-456
[27]   THE REGULATION OF IMMUNITY TO LEISHMANIA-MAJOR [J].
REINER, SL ;
LOCKSLEY, RM .
ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :151-177
[28]  
ROY M, 1993, J IMMUNOL, V151, P2497
[29]  
SADICK MD, 1986, J IMMUNOL, V136, P655
[30]   CURE OF MURINE LEISHMANIASIS WITH ANTI-INTERLEUKIN-4 MONOCLONAL-ANTIBODY - EVIDENCE FOR A T-CELL DEPENDENT, INTERFERON-GAMMA INDEPENDENT MECHANISM [J].
SADICK, MD ;
HEINZEL, FP ;
HOLADAY, BJ ;
PU, RT ;
DAWKINS, RS ;
LOCKSLEY, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :115-127